BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Cytiva acquires GoSilico to to strengthen digital capabilities in bioprocessing

GoSilico's software creates “digital twins” of downstream processes and is increasingly used to enhance process development by simulation Mo...

June 02, 2021 | News

WHO approves China's Sinovac COVID-19 vaccine for emergency use

The World Health Organisation (WHO) has validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agenc...

June 02, 2021 | News

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Changzhou, China operations become Avantor's first single-use production facility in AMEA region; doubles Avantor's global single-use cleanroom space- Adds...

June 02, 2021 | News

Henlius Received IND Approval for Its Novel Anti-CD73 mAb HLX23 from US FDA

Currently, there is no CD73 targeted product on the market around the globe. A number of early clinical studies have shown reliable safety in monotherapy o...

June 01, 2021 | News

Henlius Received IND Approval for Its Novel Anti-CD73 mAb HLX23 from US FDA

Currently, there is no CD73 targeted product on the market around the globe. A number of early clinical studies have shown reliable safety in monotherapy o...

June 01, 2021 | News

Mindray launches novel imaging technologies in China

Mindray, a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women's Healthcare,...

May 31, 2021 | News

China: Biweekly Covid19 cases: where are confirmed cases increasing or falling?

Since reporting can vary significantly from day to day – irrespectively of any actual variation of cases – it is helpful to look at a longer ti...

May 31, 2021 | Analysis

Gannex Received China IND Approval

Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-...

May 28, 2021 | News

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

Per the agreement, WuXi Biologics, as the exclusive CDMO partner will provide biologics development and cGMP manufacturing services for OncoC4’s prod...

May 27, 2021 | News

PPD Opens Multipurpose Clinical Research Laboratory in China

PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, is opening a new laboratory in Suzhou, China, to support China-base...

May 26, 2021 | News

Most COVID-19 Patients Have Long-term Neurological Problems

In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...

May 25, 2021 | Analysis

Genetron Health ,Siemens Healthineers to Promote Precision Oncology for Lung Cancer

This partnership aims to promote large scale application of Genetron’s S5 platform and lung cancer 8-gene IVD assay in Chinese hospitals, in order to...

May 17, 2021 | News

WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

Per the terms of the joint venture agreement, WuXi Biologics and WuXi STA will make capital contributions of USD120 million and USD8...

May 14, 2021 | News

Antengene Announces the IND Approval for Eltanexor

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...

May 14, 2021 | News

Stay Connected